The Clinical Operations team at Cara Therapeutics is responsible for managing and executing clinical trials to evaluate the safety and efficacy of new therapeutics targeting peripheral kappa opioid receptors. This team collaborates closely with cross-functional partners to ensure that studies are conducted in compliance with regulatory standards, timelines, and budgets, while also overseeing data management and analysis to support the advancement of innovative treatments for pruritus.
View all